Skip to main content

Table 1 Characteristics of control subjects, overweight or obese patients and diabetic patients

From: Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients

 

Control group

Overweight or obese patients

Diabetic patients

p

 

n = 25

n = 30

n = 118

 

Age, years

23 (22;25)

37 (31;49)*

61 (56;67)*†

<0.01

Gender (male/female)

15/10

3/27*

72/46

<0.01

Body mass index, kg/m2

21.7 (20.4;23.0)

34.1 (31.3;37.1)*

30.0 (26.9;34.7)*†

<0.01

Hypertension (%)

NA

7 (23.3)

103 (87.3)

<0.01

Dyslipidemia (%)

NA

12 (40.0)

103 (87.3)

<0.01

 Total cholesterol, mmol/l

 

4.7 (4.4;5.5)

4.4 (3.8;5.2)

0.05

 HDL cholesterol, mmol/l

 

1.21 (1.03;1.35)

1.08 (0.92;1.3)

0.06

 LDL cholesterol, mmol/l

 

3.17 ± 0.90

2.65 ± 0.92

<0.01

 Triglycerides, mmol/l

 

1.17 (0.90;1.79)

1.52 (1.10;2.20)

<0.05

Smoking (%)

NA

3 (10.0)

23 (19.5)

NS

FMD, %

3.95 (1.43;5.25)

4.25 (1.74;5.56)

0.61 (-1.22;3.2)*†

<0.01§

Paradoxical vasoconstriction (%)

3 (12)

3 (10.0)

47 (39.8)*†

<0.01§

VCAM, ng/ml

 

485 (435;656)

562 (430;677)

NS

  1. Data are means ± SD or median (upper limits of first and third quartiles); *: p < 0.01 vs control subjects; †: p < 0.01 vs overweight or obese patients. §: also after adjustment on age and gender.
  2. FMD: flow mediated dilation, NA: non applicable, NS: non significant, VCAM: Vascular Cellular Adhesion Molecule.